scholarly article | Q13442814 |
P2093 | author name string | Chung Lee | |
Xuemei Huang | |||
P921 | main subject | apoptotic process | Q14599311 |
prostatic hypertrophy | Q506659 | ||
P304 | page(s) | s740-9 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | Frontiers in Bioscience | Q5506062 |
P1476 | title | Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta | |
P478 | volume | 8 |
Q37115315 | A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia |
Q57213602 | Administration of extract of mushroom Phellinus linteus induces prostate enlargement with increase in stromal component in experimentally developed rat model of benign prostatic hyperplasia |
Q34485215 | CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis |
Q90226597 | Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation? |
Q64068522 | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
Q61167608 | Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression |
Q37376875 | Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines |
Q38628753 | Epithelial-mesenchymal transition in prostatic disease |
Q39013561 | Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells |
Q51008917 | Fibrillar collagen genes are not coordinately upregulated with TGF β1 expression in finasteride-treated prostate. |
Q46930324 | Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. |
Q92617057 | Hypoxia-inducible factor 1α (HIF-1α) mediates the epithelial-mesenchymal transition in benign prostatic hyperplasia |
Q64287632 | Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma |
Q33960272 | Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor |
Q37338238 | Is transforming growth factor-β signaling activated in human hypertrophied prostate treated by 5-alpha reductase inhibitor? |
Q92668881 | Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-β/Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats |
Q30425035 | Low-power GaAlAs laser irradiation promotes the proliferation and osteogenic differentiation of stem cells via IGF1 and BMP2 |
Q84346626 | Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia |
Q38077302 | Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: systematic review and meta-analysis of randomized controlled trials |
Q37364472 | Promising molecular targets and biomarkers for male BPH and LUTS |
Q55302098 | Specific expression pattern of tissue cytokines analyzed through the Surface Acoustic Wave technique is associated with age-related spontaneous benign prostatic hyperplasia in rats. |
Q33416979 | Stromal nodules in benign prostatic hyperplasia: morphologic and immunohistochemical characteristics |
Q36279487 | Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development |
Q37207618 | Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH). |
Q38238738 | The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis. |
Q42476964 | Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation |
Q37419153 | Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy |
Q37781690 | Up for Mischief? IL-17/Th17 in the tumour microenvironment |
Search more.